Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Additionally we are shipping Metabotropic Glutamate Receptor 4 Kits (15) and Metabotropic Glutamate Receptor 4 Proteins (4) and many more products for this protein.
Showing 10 out of 44 products:
Results suggest that variant rs2229901 of glutamate receptor 4 (show GRIA4 Antibodies) is associated with major depressive disorder risk. This variant probably impacts the interaction between GRM4 and miR (show MLXIP Antibodies)-1202.
Our data suggest that GRM4 gene polymorphism is closely related to the morbidity and metastasis of osteosarcoma in a Chinese population.
The GRM4 gene polymorphism was associated with the susceptibility and metastasis of osteosarcoma in a Chinese Han population.
The major depression subjects exhibited significantly higher expression level in the metabotropic receptor genes GRM4 in Locus coeruleus neurons.
explored the relationship between the binding pockets of mGlu4-positive allosteric modulators with different chemical scaffolds and their functional properties
Data show that mGlu2 (show GRM2 Antibodies) and mGlu4 subunits (but not mGlu2 (show GRM2 Antibodies) and mGlu1 (show GRM1 Antibodies)) can heteromerize.
GRM4 sequence variants might confer low-risk effects to the etiology of idiopathic generalized epilepsies.
residues shaping the binding pocket determine ligand selectivity for mGLUR4
mGluR4 has a role in 5-FU resistance in colonic neoplasms
Results suggest that overexpression of mGluR4 is associated with poor prognosis.
This immuno-electron microscopic studies suggest that pre-synaptic metabotropic glutamate receptor 4 (mGluR4) in striatal glutamatergic terminals is expressed almost exclusively in cortical boutons to subserve regulatory influences upon a large contingent of corticostriatal terminals that preferentially target putative "indirect" pathway striatal projection neurons in mice.
Study assessed the actions of the first mGlur4-selective orthosteric agonist, LSP4-2022, in several tests reflecting positive, negative, and cognitive symptoms of schizophrenia; results suggest that the interplay between mGlu4 and GABAB receptors may become the basis for a novel therapy for schizophrenic patients with predomination of positive symptoms
Results offer the first evidence that changes in the striatal expression of mGlu4 and mGlu5 (show GRM5 Antibodies) receptors occur in acute models of parkinsonisms
Involvement of multiple taste receptors in umami taste: analysis of gustatory nerve responses in metabotropic glutamate receptor 4 knockout mice
A functional hetero-complex is formed with mGluR2 (show GRM2 Antibodies) and mGluR4 in central nervous system.
mGluR4-/- mice show increased long-term potentiation in hippocampal CA1 (show CA1 Antibodies) region and improved maze learning.
data support a role for mGluR4 signaling in acquisition of fear learning and memory.
The expression of mGluR4 is down-regulated in the cardiomyocyte differentiation of embryonic stem cells.
These data indicate that effects of mGluR4 on sensorimotor function and measures of anxiety, but not cued fear conditioning, are critically modulated by sex and age.
A role for mGlu4 was found whereby simultaneous activation with GABA(A) receptors acts to amplify glutamate (show GRIN1 Antibodies) release at parallel fiber-Purkinje cell synapses.
L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Several transcript variants encoding different isoforms have been found for this gene.
metabotropic glutamate receptor 4
, G protein-coupled receptor GRM4
, G protein-coupled receptor, family C, group 1, member D